White Paper

Always Inspection Ready: Mastering FDA Inspection Preparation and Response

Free White Paper

Always Inspection Ready: Mastering FDA Inspection Preparation and Response

Inside this White Paper

With the FDA increasing unannounced and remote inspections, continuous inspection readiness is more important than ever. This whitepaper offers a focused look at preparing your facility, emphasizing internal audits and structured readiness strategies to support sustained compliance. 

Explore the current regulatory landscape of unannounced and remote inspections, pitfalls in inspection readiness, building an inspection-ready organization, and more.

This whitepaper was originally published with American Pharmaceutical Review.

Check out our Always Inspection Ready webinar.

Register to Read the Whitepaper

    Review our Terms of Use and Privacy Policy

    Presenters

    Anita Michael

    Executive Principal Consultant, Pharma Compliance

    Anita Michael has over 25 years of global pharmaceutical regulatory and quality experience. She spent 16+ years at the U.S. FDA as a Global Pharmaceutical Expert, leading nearly 300 inspections worldwide across biotech, sterile manufacturing, drug substance, and OTC product lines. Anita has held executive and director-level roles in Quality Assurance, Regulatory Affairs, and Validation. She is a recognized industry leader in GMP inspection readiness, FDA response strategy, and modern quality system design, and has been a keynote speaker at numerous global conferences. Her contributions have earned her multiple awards from both the FDA and the pharmaceutical industry.

    Begin the Regulatory Compliance Associates Scoping Process Today

    Contact Us